IMU Biosciences’ Post

IMU Biosciences reposted this

IMU Biosciences is delighted to announce that it has been accepted into the NVIDIA Inception Program, an initiative designed to support promising startups making advancements in AI, machine learning and data sciences. This partnership will provide IMU Biosciences with access to NVIDIA's state-of-the-art technology and expertise, further enhancing our ability to translate vast systems-level immune data into actionable insights for precision medicine. Key benefits of the programme include: • Advanced AI Optimisation: Direct support from NVIDIA's deep learning experts to enhance IMU's proprietary AI and machine learning analytics. • Specialised Training: Access to NVIDIA's cutting-edge AI training programs, deepening IMU's expertise in applying machine learning to complex immunological data. • Accelerated Computing Resources: Utilisation of NVIDIA's high-performance computing capabilities to speed up IMU's high-throughput, scalable immunophenotyping technologies. • Expanded Network: Opportunities to connect with NVIDIA's extensive network of AI-driven healthcare and biotech companies, as well as potential investors through the NVIDIA Inception VC Alliance. Read more on our website: https://lnkd.in/eFN9qYAG #NVIDIAInception #NVIDIA #Biotech #Immunology #Innovation #PrecisionMedicine #AI #ML

IMU Biosciences joins NVIDIA Inception Programme to Accelerate AI-Driven Precision Medicine

IMU Biosciences joins NVIDIA Inception Programme to Accelerate AI-Driven Precision Medicine

imubiosciences.com

Jeffrey Dern

Medtech and Life Sciences Business Leader | Purpose-Driven, Collaborative Strategist | Passion for Building High Performing Inclusive Teams |

4mo

Congratulation to Tom Hayday and the IMU Biosciences. This partnership is a clear win-win combining AI and further understanding the immune system. 👍

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics